Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 44, Issue 9, Pages 957-971
Publisher
Springer Science and Business Media LLC
Online
2021-06-19
DOI
10.1007/s40264-021-01086-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors
- (2021) Flora Pirozzi et al. Current Oncology Reports
- Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies
- (2021) Ashley F. Stein-Merlob et al. Current Cardiology Reports
- Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
- (2021) Roberta Noseda et al. Cancers
- Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
- (2020) Rosanna Ruggiero et al. Frontiers in Pharmacology
- Pre-Existing Cardiovascular Conditions as Clinical Predictors of Myocarditis Reporting with Immune Checkpoint Inhibitors: A VigiBase Study
- (2020) Roberta Noseda et al. Cancers
- Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System
- (2019) Emanuel Raschi et al. Targeted Oncology
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology
- (2019) Dong-Yi Chen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- A population-based study of cardiovascular disease mortality risk in US cancer patients
- (2019) Kathleen M Sturgeon et al. EUROPEAN HEART JOURNAL
- Myocarditis following the use of different immune checkpoint inhibitor regimens: A real-world analysis of post-marketing surveillance data
- (2019) Qianqian Fan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
- (2019) Yu-Wen Zhou et al. Frontiers in Pharmacology
- Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
- (2019) Julie Garon-Czmil et al. Scientific Reports
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of Renal Cell Carcinoma
- (2018) Umberto Capitanio et al. EUROPEAN UROLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
- (2017) Cristina Scavone et al. Frontiers in Pharmacology
- Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab
- (2016) Tomonori Tadokoro et al. Circulation-Heart Failure
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent developments and future challenges in immune checkpoint inhibitory cancer treatment
- (2015) Bas D. Koster et al. CURRENT OPINION IN ONCOLOGY
- Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
- (2015) Heinz Läubli et al. Journal for ImmunoTherapy of Cancer
- Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
- (2015) Benjamin P Geisler et al. Journal for ImmunoTherapy of Cancer
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More